Languages
  • Deutsch
  • English
  • Home
  • About ESfEQA
  • EQA Programs
    • Biochemistry
    • Immunology
    • Microbiology
    • Molecular Diagnostics
    • Hematology
    • Educational Programs
    • Instructions for Participants
    • Catalogue, Calendar
  • Distributors
  • Contact
  • Biochemistry
  • Immunology
  • Microbiology
    • Adenovirus
    • Aspergillus Fumigatus
    • Aspergillus Gallactomannan Antigen
    • Bacteriology
    • Borrelia
    • Borrelia IgG-Antibody Index (AI)
    • Borrelia IgM-Antibody Index (AI)
    • Brucella
    • Chagas
    • Chikungunya Virus
    • Chlamydophila Pneumoniae
    • Chlamydia Trachomatis
    • Coxsackievirus
    • Dengue Virus
    • ECHO-Virus
    • Enterovirus
    • Epstein-Barr Virus
    • Hepatitis A Virus
    • Hepatitis B Virus
    • Hepatitis E Virus
    • HIV Antibodies and Antigen
    • HTLV I/II
    • Infectious Disease Combination Control
    • Influenza A Virus
    • Influenza B Virus
    • Leptospira
    • Malaria Microscopy
    • Measles
    • Parainfluenza Virus
    • Parvovirus B19
    • Respiratory Syncytial Virus
    • SARS-CoV-2 (COVID-19) Antibodies
    • SARS-CoV-2 (COVID-19) Antigen
    • Syphilis
    • TBEV IgG-Antibody Index (AI)
    • TBEV IgM-Antibody Index (AI)
    • ToRCH
    • Varizella Zoster Virus
    • West Nile Virus
    • Zika Virus
  • Molecular Diagnostics
  • Hematology
  • Educational Programs
  • Instructions for Participants
  • Catalogue, Calendar

Infectious Disease Combination Control

2 liquid samples (minimum 0,5 mL) of human plasma. 4 surveys per year (INF4).
4 liquid samples (minimum 0,5 mL) of human plasma. 4 surveys per year (INF4x4).
2 liquid samples (minimum 0,5 mL) of human plasma. 2 surveys per year (INF2).

Analytical parameters

anti-HIV 1/2 / p24 Ag, anti-HCV, anti-HBc, HBsAg

Instructions for Use

IFU_INF2_2022_01

IFU_INF4_2022_01-02

IFU_INF4_2022_01-02_c_d

IFU_INF4x4_2022_01-02

Result Entry Form

Result-Form_INF2

Result-Form_INF4

Result-Form_INF4x4

Short Name

INF4
INF4x4
INF2

SitemapDisclaimerGeneral Terms
© 2022 ESfEQA GmbH